{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:34:05Z","timestamp":1774265645483,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571173"],"award-info":[{"award-number":["81571173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601048"],"award-info":[{"award-number":["81601048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8177051973"],"award-info":[{"award-number":["8177051973"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1916-1","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T05:17:44Z","timestamp":1558502264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Soluble glucocorticoid-induced tumor necrosis factor receptor regulates Helios expression in myasthenia gravis"],"prefix":"10.1186","volume":"17","author":[{"given":"Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1523-0338","authenticated-orcid":false,"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"1916_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14:1023\u201336.","journal-title":"Lancet Neurol."},{"key":"1916_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","volume":"14","author":"CR Grant","year":"2015","unstructured":"Grant CR, Liberal R, Mieli-Vergani G, Vergani D, Longhi MS. Regulatory T-cells in autoimmune diseases: challenges, controversies and\u2014yet\u2014unanswered questions. Autoimmun Rev. 2015;14:105\u201316.","journal-title":"Autoimmun Rev"},{"key":"1916_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.03.016","volume":"225","author":"M Masuda","year":"2010","unstructured":"Masuda M, Matsumoto M, Tanaka S, Nakajima K, Yamada N, Ido N, et al. Clinical implication of peripheral CD4+ CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients. J Neuroimmunol. 2010;225:123\u201331.","journal-title":"J Neuroimmunol"},{"key":"1916_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s10875-012-9685-0","volume":"32","author":"WH Xu","year":"2012","unstructured":"Xu WH, Zhang AM, Ren MS, Zhang XD, Wang F, Xu XC, et al. Changes of Treg-associated molecules on CD4+ CD25+ Treg cells in myasthenia gravis and effects of immunosuppressants. J Clin Immunol. 2012;32:975\u201383.","journal-title":"J Clin Immunol"},{"key":"1916_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","volume":"259","author":"EM Shevach","year":"2014","unstructured":"Shevach EM, Thornton AM. tTregs, pTregs, and iTregs: similarities and differences. Immunol Rev. 2014;259:88\u2013102.","journal-title":"Immunol Rev"},{"key":"1916_CR6","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.1038\/srep07767","volume":"5","author":"K Singh","year":"2015","unstructured":"Singh K, Hjort M, Thorvaldson L, Sandler S. Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in na\u00efve mice. Sci Rep. 2015;5:7767.","journal-title":"Sci Rep."},{"key":"1916_CR7","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/art.39091","volume":"67","author":"H Takatori","year":"2015","unstructured":"Takatori H, Kawashima H, Matsuki A, Meguro K, Tanaka S, Iwamoto T, et al. Helios enhances Treg cell function in cooperation with FoxP3. Arthritis Rheumatol. 2015;67:1491\u2013502.","journal-title":"Arthritis Rheumatol."},{"key":"1916_CR8","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1073\/pnas.1604765113","volume":"113","author":"H Nakagawa","year":"2016","unstructured":"Nakagawa H, Sido JM, Reyes EE, Kiers V, Cantor H, Kim HJ. Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity. Proc Natl Acad Sci USA. 2016;113:6248\u201353.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1916_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.autrev.2014.10.011","volume":"14","author":"MG Petrillo","year":"2015","unstructured":"Petrillo MG, Ronchetti S, Ricci E, Alunno A, Gerli R, Nocentini G, et al. GITR+ regulatory T cells in the treatment of autoimmune diseases. Autoimmun Rev. 2015;14:117\u201326.","journal-title":"Autoimmun Rev"},{"key":"1916_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/sj.gene.6364026","volume":"4","author":"JD Kim","year":"2003","unstructured":"Kim JD, Choi BK, Bae JS, Lee UH, Han IS, Lee HW, et al. Cloning and characterization of GITR ligand. Genes Immun. 2003;4:564\u20139.","journal-title":"Genes Immun"},{"key":"1916_CR11","doi-asserted-by":"publisher","first-page":"15059","DOI":"10.1073\/pnas.2334901100","volume":"100","author":"M Tone","year":"2003","unstructured":"Tone M, Tone Y, Adams E, Yates SF, Frewin MR, Cobbold SP, et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc Natl Acad Sci USA. 2003;100:15059\u201364.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1916_CR12","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1476-5381.2011.01753.x","volume":"165","author":"G Nocentini","year":"2012","unstructured":"Nocentini G, Ronchetti S, Petrillo MG, Riccardi C. Pharmacological modulation of GITRL\/GITR system: therapeutic perspectives. Br J Pharmacol. 2012;165:2089\u201399.","journal-title":"Br J Pharmacol"},{"key":"1916_CR13","doi-asserted-by":"publisher","first-page":"17100","DOI":"10.1074\/jbc.M111.316943","volume":"287","author":"A Joetham","year":"2012","unstructured":"Joetham A, Ohnishi H, Okamoto M, Takeda K, Schedel M, Domenico J, et al. Loss of T regulatory cell suppression following signaling through glucocorticoid-induced tumor necrosis receptor (GITR) is dependent on c-Jun N-terminal kinase activation. J Biol Chem. 2012;287:17100\u20138.","journal-title":"J Biol Chem"},{"key":"1916_CR14","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.4049\/jimmunol.1403076","volume":"195","author":"YH Kim","year":"2015","unstructured":"Kim YH, Shin SM, Choi BK, Oh HS, Kim CH, Lee SJ, et al. Authentic GITR signaling fails to induce tumor regression unless Foxp3+ regulatory T cells are depleted. J Immunol. 2015;195:4721\u20139.","journal-title":"J Immunol."},{"key":"1916_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1158\/2326-6066.CIR-13-0086","volume":"1","author":"DA Schaer","year":"2013","unstructured":"Schaer DA, Budhu S, Liu C, Bryson C, Malandro N, Cohen A, et al. GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability. Cancer Immunol Res. 2013;1:320\u201331.","journal-title":"Cancer Immunol Res"},{"key":"1916_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2016.06.028","volume":"67","author":"DA Knee","year":"2016","unstructured":"Knee DA, Hewes B, Brogdon JL. Rationale for anti-GITR cancer immunotherapy. Eur J Cancer. 2016;67:1\u201310.","journal-title":"Eur J Cancer"},{"key":"1916_CR17","doi-asserted-by":"publisher","first-page":"340751","DOI":"10.1155\/2013\/340751","volume":"2013","author":"X Gan","year":"2013","unstructured":"Gan X, Feng X, Gu L, Tan W, Sun X, Lv C, et al. Correlation of increased blood levels of GITR and GITRL with disease severity in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Dev Immunol. 2013;2013:340751.","journal-title":"Clin Dev Immunol"},{"key":"1916_CR18","doi-asserted-by":"publisher","first-page":"21674","DOI":"10.3390\/ijms151221674","volume":"15","author":"Y Liu","year":"2014","unstructured":"Liu Y, Tang X, Tian J, Zhu C, Peng H, Rui K, et al. Th17\/Treg cells imbalance and GITRL profile in patients with Hashimoto\u2019s thyroiditis. Int J Mol Sci. 2014;15:21674\u201386.","journal-title":"Int J Mol Sci"},{"key":"1916_CR19","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s10067-016-3280-3","volume":"35","author":"L Li","year":"2016","unstructured":"Li L, Wen W, Jia R, Li Y, Liu X, Sun X, et al. GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis. Clin Rheumatol. 2016;35:2195\u2013202.","journal-title":"Clin Rheumatol"},{"key":"1916_CR20","doi-asserted-by":"publisher","first-page":"265868","DOI":"10.1155\/2012\/265868","volume":"2012","author":"L Gu","year":"2012","unstructured":"Gu L, Xu L, Zhang X, Tan W, Wang H, Zhang M. Correlation of circulating glucocorticoid-induced TNFR-related protein ligand levels with disease activity in patients with systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:265868.","journal-title":"Clin Dev Immunol"},{"key":"1916_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nm1563","volume":"13","author":"U Grohmann","year":"2007","unstructured":"Grohmann U, Volpi C, Fallarino F, Bozza S, Bianchi R, Vacca C, et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med. 2007;13:579\u201386.","journal-title":"Nat Med"},{"key":"1916_CR22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.molimm.2007.05.013","volume":"45","author":"EM Bae","year":"2008","unstructured":"Bae EM, Kim WJ, Suk K, Kang YM, Park JE, Kim WY, et al. Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages. Mol Immunol. 2008;45:523\u201333.","journal-title":"Mol Immunol"},{"key":"1916_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1126\/science.aad0616","volume":"350","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Barnitz RA, Kreslavsky T, Brown FD, Moffett H, Lemieux ME, et al. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science. 2015;350:334\u20139.","journal-title":"Science"},{"key":"1916_CR24","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1136\/annrheumdis-2012-202216","volume":"72","author":"T Alexander","year":"2013","unstructured":"Alexander T, Sattler A, Templin L, Kohler S, Gro\u00df C, Meisel A, et al. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus. Ann Rheum Dis. 2013;72:1549\u201358.","journal-title":"Ann Rheum Dis"},{"key":"1916_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/978-0-387-89520-8_11","volume":"647","author":"G Nocentini","year":"2009","unstructured":"Nocentini G, Riccardi C. GITR: a modulator of immune response and inflammation. Adv Exp Med Biol. 2009;647:156\u201373.","journal-title":"Adv Exp Med Biol"},{"key":"1916_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/SHK.0b013e3182262c48","volume":"36","author":"M Galuppo","year":"2011","unstructured":"Galuppo M, Nocentini G, Mazzon E, Ronchetti S, Esposito E, Riccardi L, et al. GITR gene deletion and GITR-FC soluble protein administration inhibit multiple organ failure induced by zymosan. Shock. 2011;36:263\u201371.","journal-title":"Shock."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1916-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1916-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1916-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T23:31:29Z","timestamp":1590017489000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1916-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1916"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1916-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"11 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on animal and human experimentation (the Ethics Review Committee of Xiangya Hospital) and with the Helsinki Declaration of 1964 and later versions. Informed consent was obtained from all individual participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}